Patients will have access to an additional 59 new drugs through the Manitoba Pharmacare program, including Fibristal for the treatment of uterine fibroids.
Patients will have access to an additional 54 new drugs through the Manitoba Pharmacare Program, including the highly effective Holkira Pak for the treatment of hepatitis C.
Three drugs to support people living with hepatitis C are among 69 new drugs now covered under Manitoba’s pharmacare program.
An additional 94 new drugs, including two to support patients living with diabetes, will be covered under Manitoba’s Pharmacare program starting next week.
Health Minister Erin Selby announced that a drug used to treat cystic fibrosis is one of an additional 127 new medications added to Manitoba’s Pharmacare Program.
This coming week, 98 new medications will be added to the Pharmacare program in Manitoba including a widely used cancer drug that treats advanced renal cancer, pancreatic tumors and advanced breast cancer.
More brand-name and generic drugs are being added to the provincial formulary, cutting costs for families and enhancing access to drug treatments.
Manitoba’s Pharmacare Program has been expanded and enhanced, providing more affordability for families dealing with a number of health issues.
The Manitoba government has added 93 new drugs to the provincial medicare formulary and negotiated lower drug prices, which will save families $5 million annually.
The province has negotiated lower drug prices, and added more prescription drugs to the pharmacare formulary, benefiting Manitobans by saving tax payers millions of dollars and creating more choice for those families who need life-saving drugs.
